Research ArticleArticle
Open Access
Biotransformation of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, in Dogs, Rats, and Humans, In Vivo and In Vitro
Michael Gerisch, Roland Heinig, Anna Engelen, Dieter Lang, Peter Kolkhof, Martin Radtke, Johannes Platzek, Kai Lovis, Gabriele Rohde and Thomas Schwarz
Drug Metabolism and Disposition November 2018, 46 (11) 1546-1555; DOI: https://doi.org/10.1124/dmd.118.083337
Michael Gerisch
Drug Metabolism and Pharmacokinetics (M.G., A.E., D.L., M.R., G.R., T.S.), Clinical Sciences (R.H.), Cardiology Research (P.K.), and Pharmaceutical Development (J.P., K.L.), Bayer AG, Wuppertal, Germany
Roland Heinig
Drug Metabolism and Pharmacokinetics (M.G., A.E., D.L., M.R., G.R., T.S.), Clinical Sciences (R.H.), Cardiology Research (P.K.), and Pharmaceutical Development (J.P., K.L.), Bayer AG, Wuppertal, Germany
Anna Engelen
Drug Metabolism and Pharmacokinetics (M.G., A.E., D.L., M.R., G.R., T.S.), Clinical Sciences (R.H.), Cardiology Research (P.K.), and Pharmaceutical Development (J.P., K.L.), Bayer AG, Wuppertal, Germany
Dieter Lang
Drug Metabolism and Pharmacokinetics (M.G., A.E., D.L., M.R., G.R., T.S.), Clinical Sciences (R.H.), Cardiology Research (P.K.), and Pharmaceutical Development (J.P., K.L.), Bayer AG, Wuppertal, Germany
Peter Kolkhof
Drug Metabolism and Pharmacokinetics (M.G., A.E., D.L., M.R., G.R., T.S.), Clinical Sciences (R.H.), Cardiology Research (P.K.), and Pharmaceutical Development (J.P., K.L.), Bayer AG, Wuppertal, Germany
Martin Radtke
Drug Metabolism and Pharmacokinetics (M.G., A.E., D.L., M.R., G.R., T.S.), Clinical Sciences (R.H.), Cardiology Research (P.K.), and Pharmaceutical Development (J.P., K.L.), Bayer AG, Wuppertal, Germany
Johannes Platzek
Drug Metabolism and Pharmacokinetics (M.G., A.E., D.L., M.R., G.R., T.S.), Clinical Sciences (R.H.), Cardiology Research (P.K.), and Pharmaceutical Development (J.P., K.L.), Bayer AG, Wuppertal, Germany
Kai Lovis
Drug Metabolism and Pharmacokinetics (M.G., A.E., D.L., M.R., G.R., T.S.), Clinical Sciences (R.H.), Cardiology Research (P.K.), and Pharmaceutical Development (J.P., K.L.), Bayer AG, Wuppertal, Germany
Gabriele Rohde
Drug Metabolism and Pharmacokinetics (M.G., A.E., D.L., M.R., G.R., T.S.), Clinical Sciences (R.H.), Cardiology Research (P.K.), and Pharmaceutical Development (J.P., K.L.), Bayer AG, Wuppertal, Germany
Thomas Schwarz
Drug Metabolism and Pharmacokinetics (M.G., A.E., D.L., M.R., G.R., T.S.), Clinical Sciences (R.H.), Cardiology Research (P.K.), and Pharmaceutical Development (J.P., K.L.), Bayer AG, Wuppertal, Germany
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Biotransformation of Finerenone
Michael Gerisch, Roland Heinig, Anna Engelen, Dieter Lang, Peter Kolkhof, Martin Radtke, Johannes Platzek, Kai Lovis, Gabriele Rohde and Thomas Schwarz
Drug Metabolism and Disposition November 1, 2018, 46 (11) 1546-1555; DOI: https://doi.org/10.1124/dmd.118.083337
Research ArticleArticle
Biotransformation of Finerenone
Michael Gerisch, Roland Heinig, Anna Engelen, Dieter Lang, Peter Kolkhof, Martin Radtke, Johannes Platzek, Kai Lovis, Gabriele Rohde and Thomas Schwarz
Drug Metabolism and Disposition November 1, 2018, 46 (11) 1546-1555; DOI: https://doi.org/10.1124/dmd.118.083337
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement